All Roll Calls
Yes: 419 • No: 413
Sponsored By: Representative Crenshaw
Passed House
Prohibits Federal Medicaid funding for most gender-transition procedures for individuals under 18. This change amends Title XIX of the Social Security Act to list the specific surgeries, implants, and drugs that Medicaid cannot fund for minors and it outlines narrow medical exceptions.
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
If enacted, Federal Medicaid dollars would not pay for gender transition care for anyone under 18. This would apply to state plans and waivers, and to related program administrative costs. It covers surgeries and implants, plus puberty blockers and high-dose sex hormones when used for gender transition. Exceptions would be narrow: treating precocious puberty, certain medical disorders, repairs, emergencies, or restoring the body. A doctor and a parent or guardian would need to consent, and mental distress alone would not qualify. The bill defines sex as male or female for this rule and would take effect upon enactment.
Crenshaw
TX • R
Greene (GA)
GA • R
Sponsored 1/16/2025
Weber (TX)
TX • R
Sponsored 2/13/2025
Steube
FL • R
Sponsored 9/2/2025
Davidson
OH • R
Sponsored 12/16/2025
Grothman
WI • R
Sponsored 12/18/2025
Luna
FL • R
Sponsored 1/21/2026
All Roll Calls
Yes: 419 • No: 413
house vote • 12/18/2025
On Passage
Yes: 215 • No: 201
house vote • 12/18/2025
On Motion to Recommit
Yes: 204 • No: 212
Take It Personal
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in
HR21 — Born-Alive Abortion Survivors Protection Act
Mandates care and penalties for infants born alive after an abortion. This bill would set standards of care, require reporting, create criminal penalties, and allow civil suits when an infant is born alive following an abortion. - Women and families: A woman on whom an abortion is performed may sue anyone who violates the law and recover objectively verifiable medical and psychological damages, punitive damages, and statutory damages equal to three times the cost of the abortion. Courts must award reasonable attorney's fees to prevailing plaintiffs and may award fees to defendants if a suit is frivolous. - Health care practitioners and facility employees: Any practitioner present at a birth resulting from an abortion must exercise the same professional skill, care, and diligence as for any other live-born infant of the same gestational age. Practitioners or employees who know of a failure to comply must immediately report the violation to appropriate State or Federal law enforcement. - Criminal and statutory consequences: Violators face fines, up to 5 years in prison, or both, and anyone who intentionally kills a born-alive infant is punished under the murder statute. The bill also updates chapter headings and adds statutory definitions for "abortion" and "attempt."
HR1919 — Anti-CBDC Surveillance State Act
Bars the Federal Reserve from issuing a central bank digital currency (CBDC) or any similar digital asset. It would also stop Fed banks from offering accounts or financial products to individuals and prevent using a CBDC to carry out monetary policy, while leaving a narrow exception for an open, permissionless, privacy-preserving dollar-like currency. - Households and individuals: Would block the Fed from holding accounts for people or providing financial products directly, limiting any direct relationship between individuals and Federal Reserve banks. - Federal Reserve and monetary policy: Would ban the Board of Governors from testing, studying, developing, creating, or implementing a CBDC and bar the Fed and the Federal Open Market Committee from using a CBDC to conduct monetary policy. - Banks and intermediaries: Would forbid the Fed from indirectly offering a CBDC through banks or other intermediaries, but exempts a fully private, open, dollar-denominated currency that preserves cash-level privacy.
HR38 — Constitutional Concealed Carry Reciprocity Act of 2025
National concealed-carry reciprocity. This bill would create nationwide recognition of state concealed-carry licenses so people with a valid photo ID and a state permit or the right to carry in their home State could carry a concealed handgun in many other States. - Gun owners and travelers: People not federally prohibited from firearms possession who hold a state concealed-carry license or are entitled to carry in their home State could carry a concealed handgun in States that issue permits or do not ban concealed carry. Machine guns and destructive devices are excluded. It would take effect 90 days after enactment. - State and property rights: States would keep the power to prohibit or restrict concealed carry on private property and on State or local government property. The bill also lists federal public lands and agencies where carrying would be allowed in publicly accessible areas, including National Park units and Forest Service land. - Criminal and civil protections: Officers may not arrest absent probable cause that the carry falls outside the law and prosecutors must prove beyond a reasonable doubt when the defense is raised. Prevailing defendants can recover reasonable attorney fees and may sue for deprivation of rights with damages.
HRES719 — Honoring the life and legacy of Charles "Charlie" James Kirk.
Condemns political violence. The resolution condemns the assassination of Charles 'Charlie' James Kirk, honors his life and leadership, and urges swift justice while offering sympathy to his family.
HR1262 — Mikaela Naylon Give Kids a Chance Act
Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.
HR925 — Dismantle DEI Act of 2025
Bans many federal Diversity, Equity, and Inclusion (DEI) practices across the federal government. The bill would define a narrow set of "prohibited DEI practices," require agencies to end DEI offices and related programs, and block similar DEI requirements for contractors, grantees, accrediting bodies, and parts of the military and financial regulators.